glp-1 during pregnancy receptor agonist exposure with discontinuation before or early #pregnancy was associated with greater gestational weight gain and increased risk of preterm delivery, gestational #diabetes, and hypertensive disorders. https://t.co/AK53R8UJ1V GLP-1 has changed the conversation

It expires 28 days after the rubber stopper is punctured

It received FDA approval in June 2021 as an obesity medication and has already received informal endorsements from celebrities like Kim Kardashian, Elon Musk and TikTok influencers

MS medications often include interferons, monoclonal antibodies, or immunosuppressants that could theoretically interact with GLP-1 agonists, though clinical data specifically examining this overlap remains limited

Certain mental health conditions call for additional evaluation, with a referral to a mental health specialist where appropriate, before a GLP-1 is prescribed

Autonomic neuropathy, particularly CAN, is an independent risk factor for cardiovascular mortality (50,51)